Article
[Effects of EGFR-TKIs on sequential pemetrexed for advanced pulmonary adenocarcinoma].
Zhongguo fei ai za zhi = Chinese journal of lung cancer - 1 May 2012
Wang Xiangying, Liu Youru, Gao Zhiqiang, Jiang Yinling, Han Baohui, Jiang Liyan
Abstract excerpt
BACKGROUND AND OBJECTIVE: Pemetrexed and epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) were used in patients with EGFR mutation to determine their effects. This study analyzed the influence of EGFR-TKIs on pemetrexed by observing the clinical efficacy and toxicity of pemetrexed following responses to EGFR-TKIs. METHODS: Pulmonary adenocarcinoma patients were divided into EGFR-TKIs and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
